Living-donor lobar lung transplantation for primary pulmonary hypertension in an adult.
Living-donor lobar lung transplantation for primary pulmonary hypertension in an adult.
复制标题
活体肺叶移植治疗成人原发性肺动脉高压。
DOI：
10.1067/mtc.2001.115927
复制
发表时间：
2001
影响因子：
6
通讯作者：
N. Shimizu
中科院分区：
文献类型：
--
作者：
H. Date;I. Nagahiro;M. Aoe;H. Matsubara;K. Kusano;K. Goto;N. Shimizu
为了解决供体短缺的问题，活体供肺叶肺移植获得了令人满意的中位存活和功能结果。1由于移植的肺组织数量有限，这种类型的手术似乎最适合儿童和小成人2，并且几乎只适用于囊性纤维化患者。据我们所知，这是首例成人活体肺移植治疗原发性肺动脉高压(PPH)的报道。
I n an effort to address the donor shortage issue, living-donor lobar lung transplantation has been performed with satisfactory intermediate survival and functional results.1 Because a limited amount of lung tissue is transplanted, this type of operation seems to be best suited for children2 and small adults and has been applied almost exclusively in patients with cystic fibrosis. To our knowledge, this is the first reported case of living-donor lobar lung transplantation for primary pulmonary hypertension (PPH) in an adult.